Why a $21 Million Bet on a Stock Up 200% Signals Confidence in Defense Spending

StepStone Group disclosed a new 292,428-share position in Karman Holdings (NYSE:KRMN) in its Q3 13F filing, valuing the stake at about $21.1 million and making Karman its second-largest U.S. equity holding (roughly 9.9% of reportable AUM); the stock trades near $68.44, more than triple its $22 IPO price. Karman is a specialized aerospace and defense systems supplier with a $9.1 billion market cap, trailing‑12‑month revenue of $428.2 million and recent quarterly results showing record revenue of $121.8 million (+42% YoY), adjusted EBITDA of $37.7 million (31% margin) and a funded backlog of $758.2 million. The position signals institutional conviction in defense and space spending despite the stock’s run-up, but future upside depends on backlog conversion, margin discipline and sustained federal program funding rather than multiple expansion alone.

Analysis

StepStone Group disclosed a new 292,428-share position in Karman Holdings (NYSE:KRMN) in its third-quarter 13F filing, valuing the stake at about $21.11 million and making Karman the fund’s second-largest disclosed U.S. equity holding behind StubHub (STUB). The filing implies roughly a 9.9–10.4% weighting of StepStone’s reportable AUM in Karman; the stock trades at $68.44, more than triple its $22 IPO price, indicating a significant post-IPO rerating.

Karman’s fundamentals cited in the article support institutional interest: TTM revenue of $428.2 million, net income of $11.3 million, a $9.1 billion market cap, and a headline quarter with record revenue of $121.8 million (+42% YoY), adjusted EBITDA of $37.7 million (31% margin) and a funded backlog of $758.2 million (up 31% since year‑end). Those metrics point to strong operating leverage and multi‑year revenue visibility tied to missile defense, hypersonics and space launch programs.

The position signals conviction in defense and space demand, but material risks remain: the stock’s threefold run-up creates valuation sensitivity, and future returns depend on backlog conversion, margin discipline and sustained federal spending. Sentiment is moderately positive (article score ~0.45; KRMN per‑ticker 0.7) while market‑impact is modest (0.3), suggesting limited immediate market-moving effect but continued attention to execution and budget exposure is warranted.

Key Decisions for Investors

• Consider a measured, size‑controlled exposure to Karman given strong quarterly growth and a record funded backlog, but avoid concentration risk in a single idiosyncratic defense name
• Monitor upcoming quarterly results for funded backlog conversion rates and sustained adjusted EBITDA margins as the primary operational catalysts; treat missed conversion or margin erosion as a signal to trim positions
• Avoid chasing the current price after a 3x IPO run‑up—use phased entries or limit orders to manage valuation risk and potential mean reversion
• Implement position‑level risk controls or hedges to limit exposure to federal budget shifts and program execution risk, and track StepStone’s subsequent 13F updates as a proxy for institutional conviction